Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites
- First Online:
Polygala sabulosa, a folk medicine, presents dihydrostyryl-2-pyrones (DST) and styryl-2-pyrones (STY), compounds structurally similar to kavalactones. Our previous study showed that the ethyl acetate fraction (EA) and these constituents present anxiolytic-like, hypno-sedative, and anticonvulsant effects in mice.
This study investigated the role of benzodiazepine binding site (BDZ-bs) in the central effects of either EA or three DST (1, 2, and 3) and three STY (4, 5, and 7), using in vivo and in vitro assays.
Methods and results
In the elevated plus-maze (EPM), flumazenil (FMZ), a BDZ antagonist, partially blocked the anxiolytic-like effect of DST-3 or STY-4 and STY-7, but not DST-1. Using electroencephalogram (EEG), EA protected against pentylenetetrazole (PTZ)-induced convulsion in rats, an effect partially blocked by FMZ, suggesting the participation of the BDZ-bs in this action. EA also protected against the maximal electroshock (MES)-induced convulsions in mice, a profile distinct from diazepam (DZP). DST and STY compounds inhibited the [3H]-flunitrazepam ([3H]-FNZ) binding to BDZ-bs in rat cortical synaptosomes with Ki higher than 100 μM (DST-1), 41.7 μM (DST-2), 35.8 μM (DST-3), 90.3 μM (STY-4), 31.0 μM (STY-5) and 70.0 μM (STY-7). In the saturation assay, DST-3 and STY-7 competitively inhibited the binding of [3H]-FNZ to BDZ-bs with a significant decrease in apparent affinity (Kd) and no change in maximal binding (Bmax).
The present data support a partial BDZ-bs mediation of the anxiolytic-like and anticonvulsant effects of EA of P. sabulosa and its main isolated constituents, DST and STY.
KeywordsPhytomedicines Polygala sabulosa Benzodiazepine site Anxiolytic Anticonvulsant
- Ashton H (1994) Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 48(1):25–40Google Scholar
- Blumenthal M (2002) Kava safety questioned due to case reports of liver toxicity. HerbalGram 55:26–32Google Scholar
- Dhawan K, Dhawan S, Sharma A (2004) Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol 78(2–3):165–170Google Scholar
- Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12(1):12–15Google Scholar
- Mandhane SN, Aavula K, Rajamannar T (2007) Timed pentylenetetrazol infusion test: A comparative analysis with s.c. PTZ and MES models of anticonvulsant screening in mice. Seizure 16(7):636–644Google Scholar
- Polc P (1991) GABA-independent mechanisms of benzodiazepine action. In: File SE, Briley M (eds) New concepts in anxiety. London, MacMillan Publishers, pp 211–236Google Scholar
- Starr KR, Price GW, Watson JM, Atkinson PJ, Arban R, Melotto S, Dawson LA, Hagan JJ, Upton N, Duxon MS (2007) SB-649915-B, a Novel 5-HT(1A/B) Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test. Neuropsychopharmacology 32(10):2163–2172PubMedCrossRefGoogle Scholar
- Viola H, Marder M, Wasowski C, Giorgi O, Paladini AC, Medina JH (2000) 6,3′-dibromoflavone and 6-nitro-3′-bromoflavone: new additions to the 6,3′-disubstituted flavone family of high-affinity ligands of the brain benzodiazepine binding site with agonistic properties. Biochem Biophys Res Commun 273(2):694–698PubMedCrossRefGoogle Scholar